After Novavax, a US biotechnology firm which received the Emergency Use Authorization (EUA) for its Covid-19 vaccine Covovax in Indonesia, the vaccine’s local distributor, Faberco Life Sciences Inc. (Faberco) announced on Thursday that they expect to receive similar approval in the Philippines in the next few weeks. “We welcome this…